Understanding the Prevalence of Long COVID
Long COVID has become a significant area of focus in the ongoing research and treatment of COVID-19 due to its widespread impact on survivors. Numerous studies have shed light on the long-lasting effects of the disease, revealing alarming statistics.
According to research, a staggering 87 percent of individuals who were hospitalized with COVID-19 continue to experience symptoms even after 60 days from the onset of the disease. Additionally, approximately 4.5 percent of people suffer from mild symptoms that persist for more than eight weeks.
Furthermore, studies indicate that as many as half of non-hospitalized COVID-19 patients experience at least one symptom that lingers for an average of four months. Considering the global scale of COVID-19 infections, it is estimated that millions of individuals may be grappling with long COVID and its impact on the brain.
Future Research on Long COVID
As the complexity of diagnosing long COVID continues, researchers are dedicated to finding more conclusive diagnosis criteria. The National Institutes of Health (NIH) have made a commitment to investigate long COVID, aiming to uncover the root cause of its long-term symptoms, understand the varying susceptibility among individuals, and explore the possibility of COVID infection triggering lasting heart or brain disorders.